Skip to content
Recall Observatory FDA recall evidence

Drug product

Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Amgen Manufacturing Ltd., a subsidiary of Amgen Inc., Thousand Oaks, CA 91320-1799,NDC 55513-710-01, UPC 3 55513 71001 5.

D-66318-001

September 17, 2013

Class II

Product summary

Firm
Amgen, Inc.
Event
Event 66318
Status
Terminated
Classification
Class II
Quantity
4,163 prefilled syringes
Official record key
drug-enforcement:D-66318-001

Official wording

Reason: Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.

Code information: Lot #: 1037592, Exp 07/15

Distribution pattern: Nationwide and Puerto Rico, Canada, Mexico, and clinical distribution in Europe.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter